BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
Completed · Phase 2 · Has a placebo group
Conditions studied: Painful Lumbar Radiculopathy, Sciatica, Radiculopathy
In brief
The primary objective of the study is to assess the efficacy of Intravenous (IV) BG00010 (Neublastin) in improving pain in painful lumbar radiculopathy participants when administered 3 times per week for 1 week. The secondary objectives of this study in this study population are as follows: To explore the duration of the effect of BG00010 in improving pain; To explore the dose response curve on pain reduction; To assess the safety and tolerability of BG00010; To assess the serum exposure to BG00010.
Key facts
- Study ID
- NCT01873404
- Run by
- Biogen
- People needed
- 183
- Starts
- 2013-06-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2015-09-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Phoenix, Arizona, United States
- Research Site — Fresno, California, United States
- Research Site — Lomita, California, United States
- Research Site — Long Beach, California, United States
- Research Site — Pasadena, California, United States
- Research Site — Fort Lauderdale, Florida, United States
- Research Site — Orlando, Florida, United States
- Research Site — Sarasota, Florida, United States
- Research Site — St. Petersburg, Florida, United States
- Research Site — Sunrise, Florida, United States
- Research Site — Tampa, Florida, United States
- Research Site — Winter Park, Florida, United States
- Research Site — Columbus, Georgia, United States
- Research Site — Savannah, Georgia, United States
- Research Site — Bloomington, Illinois, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Evansville, Indiana, United States
- Research Site — Overland Park, Kansas, United States
- Research Site — Brockton, Massachusetts, United States
- Research Site — Lincoln, Nebraska, United States
- Research Site — Raleigh, North Carolina, United States
- Research Site — Winston-Salem, North Carolina, United States
- Research Site — Duncansville, Pennsylvania, United States
- Research Site — San Antonio, Texas, United States
- Research Site — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.